Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study
Hans-Jakob Meyer,Lukas Mödl,Olesya Unruh,Weiwei Xiang,Sarah Berger,Moritz Müller-Plathe,Gernot Rohde,Mathias W. Pletz,Jan Rupp,Norbert Suttorp,Martin Witzenrath,Thomas Zoller,Mirja Mittermaier,Fridolin Steinbeis,A Fuchs,M Engelmann,D Stolz,W Bauer,H. C Mücke,S Schmager,B Schaaf,J Kremling,D Nickoleit-Bitzenberger,H Azzaui,M Hower,F Hempel,K Prebeg,K Popkirova,M Kolditz,C Bellinghausen,A Grünewaldt,M Panning,T Welte,T Fühner,M. van’t Klooster,G Barten-Neiner,W Kröner,N Adaskina,F Eberherdt,C Julius,T Illig,N Klopp,B. T Schleenvoigt,C Forstner,A Moeser,J Ankert,D Drömann,P Parschke,K Franzen,N Käding,F Waldeck,C Spinner,J Erber,F Voit,J Schneider,D Heigener,I Hering,W Albrich,M Seneghini,F Rassouli,S Baldesberger,A Essig,S Stenger,M Wallner,H Burgmann,L Traby,L Schubert,R Chen,CAPNETZ study group
DOI: https://doi.org/10.1007/s15010-024-02292-z
2024-05-19
Infection
Abstract:Purpose Coronavirus disease 2019 (COVID-19) and non-COVID-19 community-acquired pneumonia (NC-CAP) often result in hospitalization with considerable risks of mortality, ICU treatment, and long-term morbidity. A comparative analysis of clinical outcomes in COVID-19 CAP (C-CAP) and NC-CAP may improve clinical management. Methods Using prospectively collected CAPNETZ study data (January 2017 to June 2021, 35 study centers), we conducted a comprehensive analysis of clinical outcomes including in-hospital death, ICU treatment, length of hospital stay (LOHS), 180-day survival, and post-discharge re-hospitalization rate. Logistic regression models were used to examine group differences between C-CAP and NC-CAP patients and associations with patient demography, recruitment period, comorbidity, and treatment. Results Among 1368 patients (C-CAP: n = 344; NC-CAP: n = 1024), C-CAP showed elevated adjusted probabilities for in-hospital death (aOR 4.48 [95% CI 2.38–8.53]) and ICU treatment (aOR 8.08 [95% CI 5.31–12.52]) compared to NC-CAP. C-CAP patients were at increased risk of LOHS over seven days (aOR 1.88 [95% CI 1.47–2.42]). Although ICU patients had similar in-hospital mortality risk, C-CAP was associated with length of ICU stay over seven days (aOR 3.59 [95% CI 1.65–8.38]). Recruitment period influenced outcomes in C-CAP but not in NC-CAP. During follow-up, C-CAP was linked to a reduced risk of re-hospitalization and mortality post-discharge (aOR 0.43 [95% CI 0.27–0.70]). Conclusion Distinct clinical trajectories of C-CAP and NC-CAP underscore the need for adapted management to avoid acute and long-term morbidity and mortality amid the evolving landscape of CAP pathogens.
infectious diseases